Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

955 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renal Sarcoma: A Population-Based Study.
Alevizakos M, Gaitanidis A, Korentzelos D, Basourakos SP, Burgess M. Alevizakos M, et al. Among authors: burgess m. Clin Genitourin Cancer. 2023 Feb;21(1):155-161. doi: 10.1016/j.clgc.2022.07.012. Epub 2022 Jul 30. Clin Genitourin Cancer. 2023. PMID: 36045013
ALX4::NCOA2 rearranged round and spindle cell sarcoma.
Zilla ML, Korentzelos D, Lebamoff J, Burgess MA, Naous R, John I. Zilla ML, et al. Among authors: burgess ma. Histopathology. 2024 Apr 2. doi: 10.1111/his.15189. Online ahead of print. Histopathology. 2024. PMID: 38566331 No abstract available.
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.
Schöffski P, Bahleda R, Wagner AJ, Burgess MA, Junker N, Chisamore M, Peterson P, Szpurka AM, Ceccarelli M, Tap WD. Schöffski P, et al. Among authors: burgess ma. Clin Cancer Res. 2023 Sep 1;29(17):3320-3328. doi: 10.1158/1078-0432.CCR-23-0742. Clin Cancer Res. 2023. PMID: 37382656 Free PMC article. Clinical Trial.
Immunotherapeutic approaches to sarcoma.
Burgess M, Tawbi H. Burgess M, et al. Curr Treat Options Oncol. 2015 Jun;16(6):26. doi: 10.1007/s11864-015-0345-5. Curr Treat Options Oncol. 2015. PMID: 25975445 Review.
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States.
Pollack SM, Somaiah N, Araujo DM, Druta M, Van Tine BA, Burgess MA, Chawla SP, Seetharam M, Okuno SH, Bohac C, Chen M, Yurasov S, Attia S. Pollack SM, et al. Among authors: burgess ma. Cancer Med. 2020 Jul;9(13):4593-4602. doi: 10.1002/cam4.3039. Epub 2020 May 6. Cancer Med. 2020. PMID: 32374488 Free PMC article.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: burgess ma. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Clinical Trial.
VIM::KMT2A rearranged sarcoma: a rare emerging entity.
Naous R, Skaugen JM, Zilla ML, Burgess M, John I. Naous R, et al. Among authors: burgess m. Histopathology. 2023 Nov;83(5):822-824. doi: 10.1111/his.15028. Epub 2023 Aug 14. Histopathology. 2023. PMID: 37575084 No abstract available.
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab.
Keung EZ, Burgess M, Salazar R, Parra ER, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno SH, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke D, Lazar AJ, Wang WL, Wargo JA, Tawbi HA. Keung EZ, et al. Among authors: burgess m. Clin Cancer Res. 2020 Mar 15;26(6):1258-1266. doi: 10.1158/1078-0432.CCR-19-1824. Epub 2020 Jan 3. Clin Cancer Res. 2020. PMID: 31900276 Free PMC article. Clinical Trial.
955 results